Works matching DE "PROSTATE-specific membrane antigen"
Results: 630
Preliminary evaluation of a novel PSMA-targeting radiopharmaceutical [<sup>68</sup>Ga]Ga/[<sup>177</sup>Lu]Lu–NYM032 for theranostic use in prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 5, p. 1671, doi. 10.1007/s00259-024-07046-5
- By:
- Publication type:
- Article
JHU-2545 preferentially shields salivary glands and kidneys during PSMA-targeted imaging.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 5, p. 1631, doi. 10.1007/s00259-024-07044-7
- By:
- Publication type:
- Article
Influence of dosimetry accuracy on the correlation with treatment outcome in a preliminary PSMA radiopharmaceutical therapy study.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 5, p. 1649, doi. 10.1007/s00259-024-07010-3
- By:
- Publication type:
- Article
Optimal use, combinations, and sequencing of therapies in advanced prostate cancer.
- Published in:
- Expert Review of Clinical Pharmacology, 2025, v. 18, n. 1/2, p. 13, doi. 10.1080/17512433.2025.2451643
- By:
- Publication type:
- Article
Intra-arterial administration of PSMA-targeted radiopharmaceuticals for brain tumors: is the era of interventional theranostics next?
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 10, p. 925, doi. 10.1080/14737140.2024.2398492
- By:
- Publication type:
- Article
Treatment of metastatic castration-resistant prostate cancer: review of current evidence and synthesis of expert opinions on radioligand therapy.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1530580
- By:
- Publication type:
- Article
Zinner syndrome: report of a case and whole exome sequencing.
- Published in:
- Basic & Clinical Andrology, 2025, v. 35, n. 1, p. 1, doi. 10.1186/s12610-025-00256-3
- By:
- Publication type:
- Article
Hybrid PET/CT Molecular Imaging in Carcinoma Prostate With 68Ga Labelled PSMA Ligand - A Large Single Centre Experience.
- Published in:
- European Journal of Cardiovascular Medicine, 2024, v. 14, n. 6, p. 236
- By:
- Publication type:
- Article
General Toxic Properties of the Radiopharmaceutical <sup>225</sup>Ac-DOTA-PSMA.
- Published in:
- Physics of Atomic Nuclei, 2024, v. 87, n. 12, p. 1923, doi. 10.1134/S1063778824100508
- By:
- Publication type:
- Article
Evaluation of Gallium-68 prostate-specific membrane antigen, positron emission tomography/computed tomography (GA-68 PSMA PET/CT) in recurrent prostate cancer: a retrospective review of initial clinical experience at Tygerberg Hospital.
- Published in:
- Pan African Medical Journal, 2024, v. 48, p. 1, doi. 10.11604/pamj.2024.48.30.38084
- By:
- Publication type:
- Article
Inguinal lymph node metastases from prostate cancer: clinical, pathology, and multimodality imaging considerations.
- Published in:
- Radiologia Brasileira, 2024, v. 57, p. 1, doi. 10.1590/0100-3984.2024.0013
- By:
- Publication type:
- Article
PSMA PET/CT in the Brazilian Unified Healthcare System reduces costs with futile salvage therapies in the management of cases of biochemical recurrence of prostate cancer.
- Published in:
- Radiologia Brasileira, 2024, v. 57, p. 1, doi. 10.1590/0100-3984.2024.0024
- By:
- Publication type:
- Article
Unveiling the Potential of Prostate-Specific Membrane Antigen for Precision Diagnosis and Therapy of Prostate Cancer: A Radiopharmaceutical Perspective.
- Published in:
- Malaysian Journal of Medical Sciences, 2024, v. 31, n. 4, p. 213, doi. 10.21315/mjms2024.31.4.17
- By:
- Publication type:
- Article
B-CLL with negative <sup>18</sup>F-FDG PET/CT and intensive solitary lesion on PSMA PET/CT mimicking prostate cancer bone metastases.
- Published in:
- EJNMMI Reports, 2025, v. 9, n. 1, p. 1, doi. 10.1186/s41824-024-00235-3
- By:
- Publication type:
- Article
Unexpected Metastatic Localization of Prostate Cancer Determined by Ga-68 PSMA PET/CT: Choroid.
- Published in:
- Türkiye Klinikleri Journal of Case Reports, 2022, v. 30, n. 2, p. 102, doi. 10.5336/caserep.2021-86462
- By:
- Publication type:
- Article
The Importance of Prostate-Specific Membrane Antigen Expression in Salivary Gland Tumors.
- Published in:
- Turkish Archives of Otorhinolaryngology, 2022, v. 60, n. 4, p. 206, doi. 10.4274/tao.2022.2022-12-3
- By:
- Publication type:
- Article
The Importance of Prostate-Specific Membrane Antigen Expression in Carotid Body Paragangliomas.
- Published in:
- Turkish Archives of Otorhinolaryngology, 2021, v. 59, n. 3, p. 203, doi. 10.4274/tao.2021.2021-3-17
- By:
- Publication type:
- Article
Targeting epitopes in prostate-specific membrane antigen for antibody therapy of prostate cancer.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2005, v. 8, n. 4, p. 359, doi. 10.1038/sj.pcan.4500835
- By:
- Publication type:
- Article
In vitro and preclinical targeted alpha therapy of human prostate cancer with Bi-213 labeled J591 antibody against the prostate specific membrane antigen.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2002, v. 5, n. 1, p. 36, doi. 10.1038/sj.pcan.4500543
- By:
- Publication type:
- Article
Prostate-specific membrane antigen (FOLH1): recent advances in characterising this putative prostate cancer gene.
- Published in:
- Prostate Cancer & Prostatic Diseases, 1999, v. 2, n. 4, p. 180, doi. 10.1038/sj.pcan.4500325
- By:
- Publication type:
- Article
Imply on diagnosis and early prognosis of preoperative [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in patients with suspected brain tumours of glial origin.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-024-84036-5
- By:
- Publication type:
- Article
Phase 2 trial of PSMA PET CT versus planar bone scan and CT in prostate cancer patients progressing while on androgen deprivation therapy.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-75589-6
- By:
- Publication type:
- Article
Dual FDG/PSMA PET imaging to predict lesion-based progression of mCRPC during PSMA-RLT.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-61961-z
- By:
- Publication type:
- Article
Aptamers as Theragnostic Tools in Prostate Cancer.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 8, p. 1056, doi. 10.3390/biom12081056
- By:
- Publication type:
- Article
FUSION & SCINTILLATION DOWN UNDER: Early Use in Australia & New Zealand.
- Published in:
- Gamma Gazette, 2024, n. 43, p. 50
- Publication type:
- Article
THE UTILITY OF 68GAPSMA EXPRESSION IN ADENOID CYSTIC CARCINOMA OF THE HEAD AND NECK: A CASE STUDY.
- Published in:
- Gamma Gazette, 2024, n. 41, p. 38
- By:
- Publication type:
- Article
Preparation of QDs@SiO<sub>2</sub>/Polystyrene Composite Particles for Cancer Cells Detection.
- Published in:
- Nano Life, 2018, v. 08, n. 04, p. N.PAG, doi. 10.1142/S1793984418410064
- By:
- Publication type:
- Article
Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer.
- Published in:
- Annals of Medicine, 2024, v. 56, n. 1, p. 1, doi. 10.1080/07853890.2024.2320301
- By:
- Publication type:
- Article
In Vivo 3T Magnetic Resonance Imaging Using a Biologically Specific Contrast Agent for Prostate Cancer: A Nude Mouse Model.
- Published in:
- Journal of Nanotechnology, 2017, p. 1, doi. 10.1155/2017/8424686
- By:
- Publication type:
- Article
Radiation Oncology Orals.
- Published in:
- Journal of Medical Imaging & Radiation Oncology, 2024, v. 68, p. 185, doi. 10.1111/1754-9485.13780
- Publication type:
- Article
Utility of Ga<sup>68</sup> prostate-specific membrane antigen positron-emission tomography for pre-operative staging of high-risk prostate cancer in a prospective cohort.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Lu177-PSMA therapy for men with advanced prostate cancer: Initial 18 months experience at a single Australian tertiary institution.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Five-year trends of bone scan and prostate-specific membrane antigen positron emission tomography utilization in prostate cancer: A retrospective review in a private centre.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Unexpected significant findings non-related to prostate cancer identified using combined prostate-specific membrane antigen positron emission tomography/CT and diagnostic CT scan in primary staging for prostate cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Gallium-68 PSMA uptake in adrenal adenoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The Proinflammatory Cytokine, IL-6, and its Interference with bFGF Signaling and PSMA in Prostate Cancer Cells.
- Published in:
- Inflammation, 2013, v. 36, n. 3, p. 643, doi. 10.1007/s10753-012-9586-7
- By:
- Publication type:
- Article
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor.
- Published in:
- Nature Biotechnology, 2002, v. 20, n. 1, p. 70, doi. 10.1038/nbt0102-70
- By:
- Publication type:
- Article
GENITOURINARY.
- Published in:
- Journal of Cancer Research & Therapeutics, 2024, v. 20, p. S150, doi. 10.4103/jcrt.jcrt_2124_24
- Publication type:
- Article
Investigating the bioactive compounds from Capsicum annum as a probable alternative therapy for prostate cancer treatment: a structure-based drug design approach.
- Published in:
- Pure & Applied Chemistry, 2024, v. 96, n. 5, p. 719, doi. 10.1515/pac-2023-1111
- By:
- Publication type:
- Article
Fluorescent Conjugates Based on Prostate-Specific Membrane Antigen Ligands as an Effective Visualization Tool for Prostate Cancer.
- Published in:
- Biochemistry (00062979), 2023, v. 88, n. 7, p. 953, doi. 10.1134/S0006297923070088
- By:
- Publication type:
- Article
Risk of Tumor Upstaging With Prostate-Specific Membrane Antigen Positron Emission Tomography in Patients With High-Risk Prostate Cancer.
- Published in:
- JAMA Network Open, 2022, v. 5, n. 9, p. e2231101, doi. 10.1001/jamanetworkopen.2022.31101
- By:
- Publication type:
- Article
Translational Development of a Zr-89-Labeled Inhibitor of Prostate-specific Membrane Antigen for PET Imaging in Prostate Cancer.
- Published in:
- Molecular Imaging & Biology, 2022, v. 24, n. 1, p. 115, doi. 10.1007/s11307-021-01632-x
- By:
- Publication type:
- Article
SUV<sub>95th</sub> as a Reliable Alternative to SUV<sub>max</sub> for Determining Renal Uptake in [<sup>68</sup>Ga] PSMA PET/CT.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Whole-Body Integrated [<sup>68</sup>Ga]PSMA-11-PET/MR Imaging in Patients with Recurrent Prostate Cancer: Comparison with Whole-Body PET/CT as the Standard of Reference.
- Published in:
- 2020
- By:
- Publication type:
- journal article
[<sup>68</sup>Ga]Ga-P16-093 as a PSMA-Targeted PET Radiopharmaceutical for Detection of Cancer: Initial Evaluation and Comparison with [<sup>68</sup>Ga]Ga-PSMA-11 in Prostate Cancer Patients Presenting with Biochemical Recurrence.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Semiquantitative Parameters in PSMA-Targeted PET Imaging with [<sup>18</sup>F]DCFPyL: Intrapatient and Interpatient Variability of Normal Organ Uptake.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A Review of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) in Renal Cell Carcinoma (RCC).
- Published in:
- 2019
- By:
- Publication type:
- journal article
[<sup>68</sup>Ga]PSMA PET/CT Improves Initial Staging and Management Plan of Patients with High-Risk Prostate Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Inconsistent Detection of Sites of Metastatic Non-Clear Cell Renal Cell Carcinoma with PSMA-Targeted [<sup>18</sup>F]DCFPyL PET/CT.
- Published in:
- 2019
- By:
- Publication type:
- journal article